2021 Press Releases

November 16, 2021

Strategic relationship between SCIEX and RedShiftBio® expands the reach of disruptive technology to address challenges with rapid secondary structure assessment of biotherapeutics

SCIEX to provide Microfluidic Modulation Spectroscopy (MMS) solutions for in-depth characterization of key attributes of biotherapeutics

November 01, 2021

SCIEX targets new category of analytical instrumentation to help biopharma scientists close the developability gap

icIEF-MS accelerates biotherapeutic development through identification of charge variants at the intact protein level

September 01, 2021

SCIEX presents industry first multi-capillary system for CE-SDS, the BioPhase 8800 system

Instrument ushers in a new phase of biologic characterization, empowering scientists to analyze more samples and molecules to meet next-gen drug development challenges

September 01, 2021

SCIEX builds on cadence of innovation in biopharma with Biologics Explorer

New application software enables protein characterization analysis for the ZenoTOF 7600 system

July 29, 2021

Strategic partnership between Genedata and SCIEX deepens and accelerates characterization of next generation biotherapeutics

The collaboration will drive the development of new software solutions for in-depth characterization of novel biotherapeutics during the drug development process.

June 17, 2021

SCIEX presents new accurate mass instrument, the ZenoTOF 7600 system

System delivers new capabilities for life science research and biotherapeutic development through novel ion fragmentation and increased sensitivity

June 17, 2021

SCIEX OS introduces new software with OneOmics suite and Molecule Profiler app

New introductions connect breakthrough technology to biological insight in a secure, cloud-based environment

January 21, 2021

SCIEX Acquires Intabio, a developer of precision solutions for biotherapeutic analysis through imaged cIEF-MS

Innovative charged variant analysis accelerates biologic drug development, ensuring drug safety and efficacy